However, our study provided the first evidence of YAP's pivotal role in reshaping the immunosuppressive microenvironment within post-ablation residual HCC models, thereby expanding the oncogenic landscape of YAP signaling in the context of thermal ablation. The gene discussed is YAP1; the disease is hepatocellular carcinoma.